中文 | English
Return
Total: 124 , 1/13
Show Home Prev Next End page: GO
Author:(S CUI)

1. Therapies for amyotrophic lateral sclerosis

Xusheng HUANG ; Fang CUI

Chinese Journal of Neurology 2019;52(11):952-956

2. Problems and suggestions for the application of diagnosis-related groups system in burn surgery

Hao ZHU ; Hongliang ZHAO ; Kangle CUI

Chinese Journal of Burns 2018;34(10):736-736

3. Neuro-protective effect of Levocarnitine on severe hand, foot and mouth disease after enterovirus 71 infection

Fang CHEN ; Yajie CUI ; Chunlan SONG ; Xue GU ; Peng LI ; Junhao CUI

Chinese Journal of Applied Clinical Pediatrics 2019;34(10):753-758

4. Application of CLSI EP12-A2 and EP15-A2 documents in the performance evaluation of Adenovirus IgM CLIA microparticles

Junmei YANG ; Qianqian LIU ; Ninghua CUI ; Hongqi SUN

Chinese Journal of Experimental and Clinical Virology 2019;33(4):432-436

5.Research progress of microglia in eye disease

Ling Cui

International Eye Science 2020;20(3):472-476

6.Surgical management of neonate lip and palate cleft.

Wei-min SHEN ; Jie CUI ; Jian-bing CHEN ; Shun-rong WANG

Chinese Journal of Plastic Surgery 2006;22(2):92-94

7.Chemical constituents of Hedysarum polybotrys Hand.-Mazz.

Yang ; J LIU ; F WANG ; S CUI ; C YUE

China Journal of Chinese Materia Medica 1992;17(10):615-640

8. Application of blood purification in children with severe adenoviral disease

Yun CUI ; Yucai ZHANG

Chinese Pediatric Emergency Medicine 2019;26(10):734-737

9.Efficacy of telbivudine combined with adefovir dipivoxil and pegylated interferon combined with entecavir as antiviral therapy for chronic hepatitis B: a comparative analysis

Na LI ; Wei GOU ; Weili CUI

Journal of Clinical Hepatology 2016;32(9):1714-1716

10.Sexual and reproductive health knowledge, attitude, and behavior of young migrant workers in Shanghai

Li DU ; Meng-qing CUI ; Li-ping ZHU

Shanghai Journal of Preventive Medicine 2020;32(7):539-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 124 , 1/13 Show Home Prev Next End page: GO